With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
A brain mapping study funded by the NIH reveals which cell types may be the first to be affected. New research funded by the ...
The findings suggest that Alzheimer’s treatments are most likely to help early in the disease, and that one ... related to ...